The Share
About Us
History
LP299V® probiotic strain
Contact
Career
Investor Relations
Read this in Swedish
The Share
Management & Board of Directors
Press Releases
Financial reports
Business Strategy
Financial Goals
Key Figures
Investment Case
Corporate Governance
Presentations
Financial Calendar
Information regarding public takeover offer from Symrise
Sustainability
Health Solutions
Health Areas
Mental Health
Digestive Health
Immune Health
Metabolic Health
Women's Health
Healthy Aging
Kids' Health
Oral Health
Application Areas
Dietary Supplements
Food & beverages
Probiotic Spores
Knowledge hub
Why Probi
Adding value
Customization
Manufacturing
Manufacturing Process
Production sites
FAQ - probiotics manufacturing
Quality
Partnership
Clinical Studies
Our Expertise
Scientific Collaboration
Sustainability
Our Research
English
中文
Product request
⌕
⌕
⌕
What are you looking for?
About Us
History
LP299V® probiotic strain
Contact
Career
Investor Relations
The Share
Management & Board of Directors
Press Releases
Financial reports
Business Strategy
Financial Goals
Key Figures
Investment Case
Corporate Governance
Presentations
Financial Calendar
Information regarding public takeover offer from Symrise
Sustainability
Health Solutions
Health Areas
Mental Health
Digestive Health
Immune Health
Metabolic Health
Women's Health
Healthy Aging
Kids' Health
Oral Health
Application Areas
Dietary Supplements
Food & beverages
Probiotic Spores
Knowledge hub
Why Probi
Adding value
Customization
Manufacturing
Manufacturing Process
Production sites
FAQ - probiotics manufacturing
Quality
Partnership
Clinical Studies
Our Expertise
Scientific Collaboration
Sustainability
Our Research
English
中文
Product request
Contact
Ulf Sköld
Interim CFO
Send mail
Ticker
Share Graph
Ownership
Analyst coverage
ABG Sundal Collier
– Gonzalo Artiach Castañón
Aktiespararna
– Thomas Nilsson
SEB –
Mattias Vadsten
